About 200 reports

  • CRYOTHERAPY MARKET FOR HOSPITALS & SPECIALTY CLINICS, BY REGION, 2017-2024 (USD MILLION)
  • 8.2 HOSPITALS & SPECIALTY CLINICS

CRYOABLATION IS USED TO TREAT BONE CANCER, CERVICAL CANCER, AND CANCERS OF THE EYE, KIDNEY, LIVER, LUNGS, AND PROSTATE.

  • Hospital
  • North America
  • United States
  • CooperSurgical, Inc.
  • Medtronic, Inc.
  • Biomay AG
  • Cat Allergy - Pipeline by Sementis Ltd, H2 2019

Its marketed and pipeline products are focused on helping patients suffering with eye diseases, cancer, allergic and inflammatory diseases, metabolic and cardiovascular diseases, infectious diseases, neuromuscular diseases, and rare diseases.

  • Allergy
  • Chronic Disease
  • Pathology
  • Therapy
  • Product Initiative
  • Jun 22, 2020: Verastem Oncology announces presentation of preclinical data supporting the combination of VS-6766 and Defactinib in metastatic uveal melanoma
  • CKI-27 - DRUG PROFILE

Uveal melanoma arises from the melanin-producing cells in the eye, similar to how it arises in cutaneous melanoma.

  • Cancer
  • Colorectal Cancer
  • Targeted Therapy
  • Therapy
  • Bayer AG
  • Global Radiation Therapy Market By Application, By Value
  • Global Radiation Therapy Market By Application, By Value

During their lifetime, one in five men and one in six women worldwide develop cancer, and one in eight men and one in eleven women die from the illness.

  • Cancer
  • World
  • Market Size
  • Accuray Incorporated
  • IsoRay, Inc.
  • REGENERON PHARMACEUTICALS INC
  • BIRCH POLLEN ALLERGY - PIPELINE BY S-TARGET THERAPEUTICS GMBH, H1 2020

Its marketed and pipeline products are focused on helping patients suffering with eye diseases, cancer, allergic and inflammatory diseases, metabolic and cardiovascular diseases, infectious diseases, neuromuscular diseases, and rare diseases.

  • Allergy
  • Chronic Disease
  • Therapy
  • Vaccine
  • Anergis SA
  • 5.2 MARKET DYNAMICS

For instance: In March 2019, researchers from Development, Ageing and Disease Theme, UCL Institute of Ophthalmology, and University College London (UK) collaborated in order to study the importance of RNA-sequencing in ophthalmology research for eye cancer.

  • Biotech Diagnostics
  • Genomics
  • Molecular Diagnostics
  • RNA
  • RNAi Technology
  • Nov 23, 2015: Cellceutix Receives FDA Orphan Drug Designation for Kevetrin for the Treatment of Retinoblastoma
  • Dec 01, 2015: Cellceutix Receives Rare Pediatric Disease Designation From FDA for Kevetrin for the Treatment of Retinoblastoma

Retinoblastoma is an eye cancer that begins in the retina.

  • Cancer
  • Pathology
  • Therapy
  • United States
  • Cellceutix Corporation
  • BIRCH POLLEN ALLERGY - PIPELINE BY LABORATORIOS LETI SL, H2 2019
  • REGENERON PHARMACEUTICALS INC

Its marketed and pipeline products are focused on helping patients suffering with eye diseases, cancer, allergic and inflammatory diseases, metabolic and cardiovascular diseases, infectious diseases, neuromuscular diseases, and rare diseases.

  • Allergy
  • Chronic Disease
  • Pathology
  • Therapy
  • Anergis SA
  • GLOBAL MARKETS DIRECT REPORT COVERAGE
  • FEATURED NEWS & PRESS RELEASES

Retinoblastoma is an eye cancer that begins in the retina.

  • Cancer
  • Pathology
  • Therapy
  • United States
  • Cellceutix Corporation
  • DRUG INFUSION PUMP - PRODUCT DESCRIPTION

The company offers medicines for cardiovascular conditions, diabetes, cancer, neurological problems, immune disorders, men' s health and musculoskeletal problems.

  • Clinical Trial
  • Injectable Delivery
  • Therapy
  • United States
  • Medtronic, Inc.
  • REGENERON PHARMACEUTICALS INC
  • RETINOPATHY OF PREMATURITY - PIPELINE BY RECORDATI SPA, H1 2020

The drug candidates by inhbiting TREM-## prevent the inflammatory process and cancer progression.

  • Eye Disease
  • Health Services
  • Ophthalmology
  • Therapy
  • Regeneron Pharmaceuticals, Inc.
  • PIPELINE BY REGENERON PHARMACEUTICALS INC, H1 2020
  • PIPELINE BY PFIZER INC, H1 2020

Its marketed and pipeline products are focused on helping patients suffering with eye diseases, cancer, allergic and inflammatory diseases, metabolic and cardiovascular diseases, infectious diseases, neuromuscular diseases, and rare diseases.

  • Analgesic
  • Chronic Pain
  • Monoclonal Antibody
  • Therapy
  • Pfizer Inc.
  • PIPELINE BY REGENERON PHARMACEUTICALS INC, H2 2019
  • PIPELINE BY PFIZER INC, H2 2019

Its marketed and pipeline products are focused on helping patients suffering with eye diseases, cancer, allergic and inflammatory diseases, metabolic and cardiovascular diseases, infectious diseases, neuromuscular diseases, and rare diseases.

  • Analgesic
  • Chronic Pain
  • Monoclonal Antibody
  • Therapy
  • Pfizer Inc.
  • India Confocal Microscopes Market Revenue and Forecasts to 2027 (US$ Mn)
  • 9.3.7.1 India Confocal Microscopes Market Revenue and Forecasts to 2027 (US$ Mn)

Figure ##. ##.

  • Diagnostic Imaging
  • Medical Device
  • Microscope
  • Forecast
  • Market Size
  • R&D Progress Research and Development Brief
  • ANTISENSE RNAI OLIGONUCLEOTIDE TO INHIBIT ICAM-1 FOR RETINAL DISEASES AND CANCER - DRUG PROFILE

These molecules are believed to play an important role in diseases of the eye, cancer, immune disorders, and inflammatory diseases.

  • Healthcare
  • Pharmaceutical
  • Therapy
  • United States
  • Product Initiative
  • PIPELINE BY PHARMABCINE INC, H1 2020
  • PIPELINE BY MOMENTA PHARMACEUTICALS INC, H1 2020

Serious ocular treatment-emergent adverse events in the study eye occurred in ## and ## patients in the EYLEA treatment groups and ## patient in the sham injection group.

  • Biosimilar
  • Ophthalmology
  • Pharmaceutical
  • Therapy
  • Regeneron Pharmaceuticals, Inc.
  • PHARMABCINE INC
  • PIPELINE BY PHARMABCINE INC, H1 2020

Serious ocular treatment-emergent adverse events in the study eye occurred in ## and ## patients in the EYLEA treatment groups and ## patient in the sham injection group.

  • Biosimilar
  • Eye Disease
  • Ophthalmology
  • Therapy
  • Regeneron Pharmaceuticals, Inc.
  • Bayer Sales and Net Income (2014-2018)
  • 6.1 Bayer

Within the prescription medicines, the sales grew for eye medicine, cancer drugs and pulmonary hypertension treatment medicine.

  • Pharmaceutical
  • Vaccine
  • Veterinary Healthcare
  • World
  • Merck & Co., Inc.
  • Products under Development by Companies, H2 2019 (Contd..1), H2 2019
  • Traumatic Pain

It was also under development for cancer pain and local pain.

  • Cardiovascular Disease
  • Heart Failure
  • Hospital
  • Therapy
  • Novartis AG
  • PIPELINE BY PHARMABCINE INC, H2 2019
  • PHARMABCINE INC

Serious ocular treatment-emergent adverse events in the study eye occurred in ## and ## patients in the EYLEA treatment groups and ## patient in the sham injection group.

  • Biosimilar
  • Eye Disease
  • Ophthalmology
  • Therapy
  • Regeneron Pharmaceuticals, Inc.
  • PIPELINE BY NEUROTEZ INC, H2 2019
  • PIPELINE BY JYANT TECHNOLOGIES INC, H2 2019

Its marketed and pipeline products are focused on helping patients suffering with eye diseases, cancer, allergic and inflammatory diseases, metabolic and cardiovascular diseases, infectious diseases, neuromuscular diseases, and rare diseases.

  • Dermatological Condition
  • Diabetes
  • Pharmaceutical
  • Therapy
  • United States
  • PIPELINE BY PHARMABCINE INC, H2 2019
  • PHARMABCINE INC

Serious ocular treatment-emergent adverse events in the study eye occurred in ## and ## patients in the EYLEA treatment groups and ## patient in the sham injection group.

  • Biosimilar
  • Eye Disease
  • Pharmaceutical
  • Therapy
  • Regeneron Pharmaceuticals, Inc.
  • Forecast
  • 41.2.1 United Kingdom - Patients Treated with Proton Therapy Actual Number and

Currently the UK has only one Proton Therapy facility, at Clatterbridge cancer center, and it' s a low-energy' machine, only suitable for treating people with rare eye cancers.

  • Hospital
  • Specialty Hospital
  • Forecast
  • Market Size
  • Hitachi, Ltd.
  • PIPELINE BY NEUROTEZ INC, H1 2019
  • PIPELINE BY JYANT TECHNOLOGIES INC, H1 2019

Its marketed and pipeline products are focused on helping patients suffering with eye diseases, cancer, allergic and inflammatory diseases, metabolic and cardiovascular diseases, infectious diseases, neuromuscular diseases, and rare diseases.

  • Dermatological Condition
  • Diabetes
  • Pathology
  • Pharmaceutical
  • Therapy
  • GLOBAL MARKETS DIRECT REPORT COVERAGE

ONE DROP OF ## G/ ML LUBRICIN IS EFFECTIVE IN REDUCING THE INSTANTANEOUS SYMPTOMS OF DRY EYE DISEASE FOR UP TO ## MINUTES.

  • Hospital
  • Immunotherapy
  • Pharmaceutical
  • Therapy
  • TaiwanJ Pharmaceuticals Co., Ltd.
  • GLOBAL MARKETS DIRECT REPORT COVERAGE

It develops antagonists for orphan nuclear receptor steroidogenic factor-##, to treat adrenocortical cancer and Cushing' s syndrome.

  • Autoimmune Disease
  • Immunology
  • Pharmaceutical
  • Therapy
  • United States
  • INDIA ELECTRORETINOGRAPHY MARKET REVENUE AND FORECASTS TO 2027 (US$ THOUSANDS)
  • 9.3 ASIA PACIFIC ELECTRORETINOGRAPHY MARKET

The other rising problems related to the eye is retinoblastoma which is a rare form of eye cancer.

  • Diagnostics
  • Electrodiagnosis
  • Healthcare
  • Forecast
  • Market Size
  • REGENERON PHARMACEUTICALS INC
  • FAMILIAL AMYLOID NEUROPATHIES - PIPELINE BY REGENERON PHARMACEUTICALS INC, H1 2020

Three (##. ##percent) participants in the OLE had died, two due to disease progression and one due to cervical cancer.

  • Endocrine Disease
  • Neurology
  • Therapy
  • Type 2 Diabetes
  • Alnylam Pharmaceuticals, Inc.
  • PIPELINE BY PRECISION BIOSCIENCES INC, H1 2020
  • PIPELINE BY PROCLARA BIOSCIENCES INC, H1 2020

Three (##. ##%) participants in the OLE had died, two due to disease progression and one due to cervical cancer.

  • Cardiology
  • Endocrine Disease
  • Hospital
  • Therapy
  • Alnylam Pharmaceuticals, Inc.
  • ANTISENSE RNAI OLIGONUCLEOTIDE TO INHIBIT ICAM-1 FOR ONCOLOGY AND RETINAL DISEASES - DRUG PROFILE

These molecules are believed to play an important role in diseases of the eye, cancer, immune disorders, and inflammatory diseases.

  • Healthcare
  • Pharmaceutical
  • Therapy
  • United States
  • Product Initiative